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Abstract: Brown adipose tissue (BAT) function may depend on its anatomical location and 
developmental origin. Interscapular BAT (iBAT) regulates acute macronutrient metabolism, whilst 
perivascular BAT (PVAT) regulates vascular function. Although phenotypically similar, whether 
these depots respond differently to acute nutrient excess is unclear. Given their distinct anatomical 
locations and developmental origins and we hypothesised that iBAT and PVAT would respond 
differently to brief period of nutrient excess. Sprague-Dawley rats aged 12 weeks (n=12) were fed 
either a standard (10% fat, n=6) or high fat diet (HFD: 45% fat, n=6) for 72h and housed at 
thermoneutrality. Following an assessment of whole body physiology, fat was collected from both 
depots for analysis of gene expression and the proteome. HFD consumption for 72h induced rapid 
weight gain (c. 2.6%) and reduced serum non-esterified fatty acids (NEFA) with no change in either 
total adipose or depot mass. In iBAT, an upregulation of genes involved in insulin signalling and 
lipid metabolism was accompanied by enrichment of lipid-related processes and functions, plus 
glucagon and peroxisome proliferator-activated receptor (PPAR) signalling pathways. In PVAT, 
HFD induced a pronounced down-regulation of multiple metabolic pathways which was 
accompanied with increased abundance of proteins involved in apoptosis (e.g. Hdgf and Ywaq) and 
toll-like receptor signalling (Ube2n). There was also an enrichment of DNA-related processes and 
functions (e.g. nucleosome assembly and histone exchange) and RNA degradation and cell adhesion 
pathways. In conclusion, we show that iBAT and PVAT elicit divergent responses to short-term 
nutrient excess highlighting early adaptations in these depots before changes in fat mass. 
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1. Introduction 
Adipose tissue function differs with its anatomical location and developmental origin [1]. For 
instance, whilst interscapular brown adipose tissue (iBAT) shares its lineage with skeletal muscle 
(e.g. Myf5+), perivascular brown adipose tissue (PVAT) is thought to derive from vascular smooth 
muscle cells (e.g. SM22α+) [1,2]. iBAT can play a role in whole body glucose, and lipid homeostasis 
as well as thermoregulation through the activation of uncoupling protein 1 (UCP1) which dissipates 
chemical energy as heat bypassing the conversion of ADP to ATP [3–5]. Despite PVAT being 
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phenotypically similar to iBAT, i.e. abundant in UCP1 and other thermogenic genes, its primary 
physiological role is the regulation of vascular function rather than systemic metabolism per se [2]. 
Dysfunctional BAT may contribute to obesity and associated metabolic disease, whereas 
compromised PVAT may enhance the atherogenic processes due to its close proximity to and 
crosstalk with the endothelium [6,7].  
The effect of diet-induced obesity on BAT is well established [8], but less is known on its 
response to brief periods of high-fat feeding. Central inflammation occurs after only 3-4 days of 
commencing a high-fat diet (HFD) that is accompanied with central and peripheral insulin resistance, 
adipose tissue inflammation and hepatic steatosis [9–16]. In humans, insulin resistance can be 
induced after 24h of a saturated-fatty acid (SFA) rich diet, with longer periods of overfeeding causing 
similar results to those seen in animal models [17]. Although both iBAT and PVAT contain abundant 
UCP1 and express glycolytic/lipolytic genes [18], their response to brief nutrient excess is unclear. 
Therefore, we determined whether iBAT and PVAT differ in their response to a short-term (i.e. 72h) 
caloric surplus. Given the evidence that ambient housing temperature is a critical factor in 
determining adipose tissue function [19,20], we determined the response to a HFD at 
thermoneutrality (Tn, 28-30°C) so as to mimic human physiology by studying BAT under basal 
conditions (i.e. when UCP1 is not active).  
2.  Materials and Methods  
All studies were approved by the University of Nottingham Animal Welfare and Ethical Review 
Board, and were carried out in accordance with the UK Animals (Scientific Procedures) Act of 1986. 
Twelve male Sprague-Dawley rats aged 8 weeks were purchased from Charles River (Kent, UK). 
Animals were randomised (http://www.graphpad.com/quickcalcs/randomize1.cfm) to either the 
control or intervention group. The study was carried out at thermoneutrality (c. 28⁰C) to negate any 
confounding effects of active BAT on the response to nutrient excess, and animals were acclimated 
to this environment for 4 weeks. Following the 4 week acclimation, all animals were weighed and 
received either the control diet (824050 SDS, Kent, UK) or a 45% high-fat (HFD, n=6) diet (824018 SDS, 
Kent, UK) for 72h. During this time, animals had ad libitum access to food and water and all 
procedures were carried out under a 12:12-hour reverse light-dark cycle (i.e. the during the active 
phase) so as to minimise animal stress and maximise data quality and translatability [21]. 
2.1. Metabolic cages 
All animals were placed in an open-circuit calorimeter known as the ‘comprehensive laboratory 
animal monitoring system’ (CLAMS: Columbus Instruments, Linton Instrumentation, Diss, UK) for 
the last 48h of the study. Oxygen consumption (VO2) and carbon dioxide production (VCO2) were 
measured [22] and were then used to calculate energy expenditure (EE) and respiratory exchange 
ratio (RER) [23,24], as previously described. Measurements were taken at 9 minute intervals for the 
last 24h. At the end of the 24h period, all animals were weighed and fasted overnight prior to 
euthanasia by rising CO2 gradient. Relevant tissues were then rapidly dissected, weighed, snap-
frozen in liquid nitrogen and stored at -80°C for subsequent analysis. PVAT was dissected from the 
aortic arch down the thoracic aorta [25]. 
2.2. Gene expression analysis 
Total RNA was extracted from iBAT and PVAT with the RNeasy Plus Micro extraction kit 
(Qiagen, West Sussex, UK) using an adapted version of the single step acidified phenol-chloroform 
method. RNA purity was subsequently quantified with the Nanodrop ND-100 (Nanodrop 
Technologies, Wilmington, USA) and all samples were normalised to 1 ng μL-1. Reverse transcription 
was carried out using the High Capacity RNA-to-cDNA kit (Life Technologies, Paisley, UK) and 
cDNA was then amplified on a Touchgene Gradient thermocycler (Techne Inc, Bibby Scientific 
Limited, Staffordshire, UK). Genes regulating thermogenesis, insulin signalling and energy 
metabolism were analysed by quantitative PCR on the Step One Plus q-PCR system and v.2.2 
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software (Applied Biosciences) using either iTaq Universal SybrGreen mastermix (BioRad, Watford, 
UK) or Taqman universal mastermix (ThermoFisher, Loughborough, UK) with rat-specific 
oligonucleotide primers (Sigma, Gillingham, UK) or FAM-MGB Taqman probes (see Supp Table 1 
and 2 for primer list). Gene expression was determined using the GeNorm algorithm against two 
selected reference genes: YWHAZ and TBP (stability value M = 0.18 in BAT and 0.25 in PVAT).  
2.3. Targeted insulin resistance PCR arrays 
We utilised the Insulin Resistance (SAB target list) PCR Array (BioRad) to screen for 86 genes 
involved in the onset of adipose tissue insulin resistance (n=3 per group). All procedures were carried 
out according to manufacturers’ instructions. Validation of representative data is shown in 
Supplementary data (Supp Figure 2).  
2.4. Serum analysis 
Serum was thawed gently on ice with concentrations of glucose (GAGO-20, Sigma Aldrich, 
Gillingham, UK), triglycerides (LabAssay ™ Trigylceride, Wako, Neuss, Germany), non-esterified 
fatty acids (NEFA)-HR(2), (Wako) and insulin (80-INSRT-E01, Alpco, Salem, NH, USA) measured 
following manufacturer’s instructions.  
2.5. Protein Extraction, clean-up and trypsinization 
Proteins were extracted by homogenisation of c. 50-100 mg of frozen tissue in 500 μL CellLytic 
MT cell lysis buffer (Sigma, C3228) and 5 μL of Halt Protease Inhibitor Cocktail (Thermo, 78430) with 
subsequent centrifugation at 20,000 x g for 10 min. The concentration of each supernatant was 
determined using the Pierce BCA Protein Assay Kit (Thermo, 23225) prior to storage at -80°C. Lipid 
and other contaminants were removed from 100 μL of each protein lysate using the ReadyPrep 2D 
cleanup Kit (Biorad, 1632130) with the final protein pellet reconstituted in 100 μL of 50 mM TEAB 
buffer (6 M Urea, pH 8.0). Following quantification of the post-clean up concentration each sample 
was normalised (50 ug) and 5 μL of 200 mM DTT/50 mM TEAB (pH 8.0) was added to each for the 
reduction of proteins over a 1 h period. Following this, 20 μL of 200 mM Iodoacetamide/50 mM TEAB 
(pH 8.0) was added for alkylation (1 h) and finally, 20 μL of 200 mM DTT/50 mM TEAB (pH 8.0) to 
consume unreacted Iodoacetamide (1 h) with the latter two incubations carried out in the dark. 775  
μL of 50 mM TEAB was then added to reduce the urea concentration to c. 0.6 M and Sequencing 
Grade Modified Trypsin (Promega, V5113) solution was added in a final concentration of 1:20 (w:w 
trypsin/protein). All samples were gently vortexed and incubated overnight for 18 h at 37°C, 
following which 2.5 μL of formic acid was added to reduce the pH and halt trypsin activity. All 
samples were then dried down at 60°C for 4 h and stored at 80°C before resuspending in liquid 
chromatography mass spectrometry (LCMS) grade 5% acetonitrile in 0.1% formic acid for subsequent 
analysis.  
2.6. Mass spectrometry  
Samples (4 μL) were injected by Eksigent 425 LC system onto a trap column (Mobile Phase A; 
0.1% formic acid, B; Acetonitrile with 0.1% formic acid; YMC Triart C18 guard column 0.3 x 5 mm, 300 
μm ID) at 10 μL/min mobile phase A for 2 min before gradient elution onto the analytical column 
(YMC Triart C18 150 x 0.3mm ID, 3 μm) in line to a Sciex TripleTOF 6600 Duospray Source using a 50 
μm electrode, positive mode +5500V.  Samples were analysed in both IDA (Information Dependent 
Acquisition, for the generation of a spectral library) and SWATH (Data Independent Acquisition, to 
generate quantitative data) modes. The following linear gradients were used: for IDA, mobile phase 
B increasing from 2% to 30% over 68 min; 40% B at 72 min followed by column wash at 80% B and 
re-equilibration (87 min total run time).  For SWATH, 3-30% B over 38 min; 40% B at 43 min followed 
by wash and re-equilibration as before (57 min total run time). IDA acquisition mode was used with 
a top 30 ion fragmentation (TOFMS m/z 400-1250; product ion 100-1500) followed by 15 sec exclusion 
using rolling collision energy, 50 ms accumulation time; 1.8 s cycle. SWATH acquisition was using 
Nutrients 2019, 11, 1065 4 of 14 
 
100 variable windows (optimised on sample type) 25 ms accumulation time, 2.6 s cycle (m/z 400-1250). 
IDA data was searched together using ProteinPilot 5.0.2, iodoacetamide alkylation, thorough search 
with emphasis on biological modifications (Swissprot rat database June 2018). SWATH data was 
analysed using Sciex OneOmics software [26] extracted against the locally generated library with the 
parameters 12 peptides per protein, 6 transitions per peptide, XIC width 30 ppm, 5 min retention time 
window. 
2.7. Statistical analysis 
Statistical analysis was performed in GraphPad Prism version 8.0 (GraphPad Software, San 
Diego, CA). Data are expressed as Mean ± SEM and details of specific statistical tests are given in 
figure legends.  
Functional analysis of the proteome was performed using the Advaita Bioinformatic 
iPathwayGuide software (www.advaitabio.com/ipathwayguide.html) with a fold change ± 0.5 and 
confidence score cut-off of 0.75. Significantly impacted biological processes, molecular interactions 
and pathways were analysed in the context of pathways obtained from the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (Release 84.0+/10-26, Oct 17) [27] and the Gene Ontology 
Consortium database (2017-Nov) [28]. The Elim pruning method, which removes genes mapped to a 
significant gene ontology (GO) term from more general (higher level) GO terms, was used to 
overcome the limitation of errors introduced by considering genes multiple times [29]. 
3. Results 
3.1. Short-term HFD downregulates genes involved in thermogenesis in PVAT only 
As expected, the short period of consuming a HFD did not cause any difference in final body 
weight between groups (Figure 1A), or in total fat mass (Control: 22.87±3.31; HFD: 23.51±3.68 g) or 
the weight of individual fat depots (Supp. Table 3). Increased 24h energy intake (Figure 1B) led to a 
small but significant increase final body weight (Figure 1C) equal to c. 2.6% body weight. Whilst there 
was no change in ambulatory activity or energy expenditure (Figures 1D, 1F, Suppl. Figure 1) the 
reduction in RER (Figure 1E) reflects a shift towards fat as the major fuel substrate in the HFD group. 
Interestingly, despite this rapid weight gain, there were no differences in serum insulin, glucose or 
triglycerides, although NEFA was reduced (Figure 1G-J). Thermogenic genes in BAT were 
unaffected, whereas PVAT was more susceptible to the HFD (Figure 2A and C). Despite similar UCP1 
messenger RNA (mRNA), there was a reduction in gene expression for β3AR, DIO2 and PRDM16 in 
PVAT. There were no differences with the HFD in PGC1α, CIDEA, FGF21, CITED1, SLC36a2 or 
P2RX5 in iBAT, whilst only SLC36a2 was reduced in PVAT. Markers of beige adipocytes, TBX1 and 
TMEM26, were expressed in both iBAT and PVAT and the HFD only reduced TMEM26 in iBAT. The 
white adipocyte specific cell-surface marker, ASC1 [30], was expressed in both iBAT and PVAT and 
reduced with HFD in the latter. 
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Figure 1. High fat diet (HFD) modified total energy balance but had no effect on insulin, glucose, triglycerides or non-esterified fatty acids. (A) Final body weight, (B) 24h 2 
energy intake, (C) 3 day weight gain, (D) 24h energy expenditure (EE), respiratory exchange ratio (RER) and ambulatory activity and (E) serum metabolites. Data expressed 3 
as mean ± SEM, n=6 per group. For comparison, data was analysed by either Students t-test (A-C, E) or two-way ANOVA (D) and Sidak post-hoc tests. Significance denoted 4 
as * < 0.05; ** < 0.01 or *** < 0.001. 5 
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Figure 2. Summary of the effect of the HFD on differences in thermogenic genes involved in brown 
adipose tissue (BAT), beige and WAT adipocyte function in interscapular BAT (iBAT) (A) and 
perivascular BAT (PVAT) (C). Top 20 up/down-regulated genes involved in adipose tissue insulin 
resistance in iBAT (B) and PVAT (D). Data expressed as mean (A and C, n=5-6) or fold change (B and 
D, n=3). Data were analysed by Students t-test (A and C) with significance denoted as * < 0.05 or ** < 
0.01. 
3.2. Short-term HFD alters insulin signalling pathways in a depot-specific manner 
Due to the marked reduction in thermogenic genes in PVAT in response to the HFD, a number 
of genes that regulate insulin signalling and energy metabolism were measured to determine if these 
were affected by short-term nutrient excess. Targeted array profiling demonstrated that genes 
involved in insulin signalling (i.e. Igf1, Insr, and Mapk3) and lipid metabolism (i.e. Hsl, Lpl, Acsl1 
and Srebf2) were upregulated in iBAT (Figure 2B and D). iBAT also exhibited increased expression 
of genes associated with ‘whitening’ (i.e. Lep, Retn and Adipoq) and inflammation (i.e. Tlr4, Emr1 
and Tnfrsf1b). Only four genes were down-regulated in iBAT including Pdk2 and Il6. PVAT exhibited 
a marked upregulation of Ccr4 and Cxcr3 which govern T-cell differentiation and infiltration. The 
HFD increased in markers of inflammasome activation, Pycard, Il1β and Casp1 in PVAT, concomitant 
with a down-regulation of genes governing lipid (i.e. Hsl, Pde3B, Acacb and Ppara) and glucose 
metabolism (i.e. Cs, Gys1, Irs2 and mTOR). 
3.3. Short-term high fat feeding induces divergent alterations in the BAT and PVAT proteome 
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As the HFD induced clear differences in depot response, we analysed the proteome to identify 
novel proteins and pathways regulated by short-term high-fat feeding. A total of 107 proteins were 
differentially regulated in iBAT with those involved in the 20S core proteasome complex (Psma3l, 
↑), endocytosis (Vps4a, ↓), calcium signalling (Camk2d, ↓) and glycolysis (Pkm, ↑) amongst the 
most significant (Table 1). In PVAT, 183 proteins were differentially regulated including those 
involved in glycolysis (Pfkp, ↓), apoptosis (Hdgf,↑; Ywhaq, ↑ and Ghitm, ↓), TLR signalling 
(Ube2n, ↑) and peroxisomal lipid metabolism (Acox1, ↓) (Table 2). 
Table 1. Top 10 differentially regulated proteins in BAT. 
Symbol Gene name Entrez Logfc Adjpv 
Psma3l Proteasome subunit alpha type-3 408248 0.793509 0.000116 
Tmem126a Transmembrane protein 126A 293113 -1.83882 0.000185 
Ssr3 Signal Sequence Receptor Subunit 3 81784 -1.61099 0.0002 
Ccdc51 Coiled-Coil Domain Containing 51 316008 -0.693 0.000763 
Pkm Pyruvate Kinase M1/2 25630 0.7335 0.00279 
Vps4a Vacuolar Protein Sorting 4 Homolog A 246772 -0.71726 0.003363 
Apoa4 Apolipoprotein A4 25080 -1.0162 0.004051 
Prss1 Serine Protease 1 24691 0.827668 0.005684 
Serpina3n Serpin Family A Member 3 24795 -0.58665 0.006792 
Camk2d Calcium/Calmodulin Dependent Protein Kinase II Delta 24246 -2.55115 0.007442 
Entrez gene ID (Entrez), log fold change (Logfc) where minus symbol equals downregulation, 
adjusted P value (adjPval). 
Table 2. Top 10 differentially regulated proteins in PVAT 
Symbol Gene name Entrez Logfc Adjpv 
Pfkp Phosphofructokinase, Platelet 60416 -1.38584 0.000225 
Hdgf Heparin Binding Growth Factor 114499 0.69362 0.000445 
Rbmxrtl RNA-binding motif protein, X chromosome retrogene-like 307779 1.91652 0.001389 
Ywhaq 14-3-3 Protein Theta 25577 0.613265 0.001405 
Ghitm Growth Hormone Inducible Transmembrane Protein 290596 -0.71467 0.001854 
Capza1 Capping Actin Protein Of Muscle Z-Line Subunit Alpha 1 691149 1.194102 0.002081 
Mtpn Myotrophin 79215 0.669685 0.002234 
Ube2n Ubiquitin Conjugating Enzyme E2 N 116725 0.80585 0.002495 
B2m Beta-2- 
Microglobulin 
24223 0.809804 0.002742 
Acox1 Acyl-CoA Oxidase 1 50681 -3.50641 0.004222 
Entrez gene ID (Entrez), log fold change (Logfc) where minus symbol equals downregulation, 
adjusted P value (adjPval). 
Gene ontology (GO) analysis demonstrated the proteins in iBAT (Table 3) were significantly 
enriched for lipid-related processes and functions including positive regulation of lipid catabolic process, 
high-density lipoprotein particle assembly, phosphatidylcholine-sterol O-acyltransferase activator activity and 
very-low-density lipoprotein particle. In PVAT (Table 4), however, proteins were significantly enriched 
for nuclear and DNA-related processes and functions, including nucleosome assembly, histone exchange, 
sequence-specific DNA binding and nuclear chromosomes. Impact analysis, which combines classical 
overrepresentation analysis with the perturbation of a given pathway, demonstrated that fat and 
digestion, glucagon signalling and peroxisome proliferator-activated receptor (PPAR) signalling 
pathways were amongst those impacted in iBAT (Figure 3A-D) whilst RNA degradation, cell adhesion 
molecules and ribosome pathways were among those impacted in PVAT (Figure 3E-G). 
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Table 3. GO terms enriched in BAT. 
GoId GoName CountDE CountAll Pv_elim 
Biological Process 
GO:0039536 negative regulation of RIG-I signaling pathway 3 3 0.0011 
GO:0050996 positive regulation of lipid catabolic process 4 6 0.0014 
GO:0046470 phosphatidylcholine metabolic process 5 7 0.0038 
GO:0030300 regulation of intestinal cholesterol absorption 3 4 0.004 
GO:0034380 high-density lipoprotein particle assembly 3 4 0.004 
Molecular Function 
GO:0031210 phosphatidylcholine binding 3 3 0.0011 
GO:0060228 phosphatidylcholine-sterol O-acyltransferase 
activator activity 
3 4 0.004 
GO:0003713 transcription coactivator activity 4 8 0.0054 
GO:0001047 core promoter binding 3 5 0.0091 
GO:0017127 cholesterol transporter activity 3 5 0.0091 
Cellular Component 
GO:0034366 spherical high-density lipoprotein particle 3 4 0.0041 
GO:0042627 chylomicron 3 4 0.0041 
GO:0005667 transcription factor complex 3 6 0.0174 
GO:0034361 very-low-density lipoprotein particle 3 6 0.0174 
Table 4. GO terms enriched in PVAT. 
GoId GoName CountDE CountAll Pv_elim 
Biological Process 
GO:0006334 nucleosome assembly 8 10 0.00023 
GO:0017144 drug metabolic process 5 8 0.00287 
GO:0043486 histone exchange 3 3 0.00343 
GO:1901655 cellular response to ketone 8 21 0.00825 
GO:0021766 hippocampus development 6 14 0.0116 
Molecular Function 
GO:0042393 histone binding 7 8 0.000011 
GO:0003785 actin monomer binding 3 3 0.0033 
GO:0043565 sequence-specific DNA binding 8 23 0.0143 
GO:0035091 phosphatidylinositol binding 5 8 0.0219 
GO:0005506 iron ion binding 6 16 0.0227 
Cellular Component 
GO:0000788 nuclear nucleosome 3 3 0.0035 
GO:0000784 nuclear chromosome, telomeric region 3 4 0.0123 
GO:0030054 cell junction 38 183 0.0174 
GO:0071013 catalytic step 2 spliceosome 5 12 0.0246 
GO:0001931 uropod 3 5 0.0273 
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Figure 3. Overview of alterations in the proteome of iBAT and PVAT following 72h of high fat feeding. Impact analysis: iBAT (A), PVAT (E); Most impacted pathways: 
iBAT (B), PVAT (F); Proteins altered in specified pathways: iBAT (C and D), PVAT (G and H).Figures created with Advaita Bio IPathwayGuide using only differentially 
altered proteins. Peroxisome proliferator-activated receptor (PPAR).  
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4. Discussion 
Brown adipose tissue plays a major role in regulating whole body glucose and lipid homeostasis 
under cold conditions (i.e. when UCP1 is active) with apparent anti-obesity potential in rodents [8]. 
Here, we demonstrate that when animals are housed at thermoneutrality (i.e. when UCP1 is not 
active) short-term exposure to a HFD is sufficient to induce rapid whole-body weight gain which 
may be due to uptake of circulating NEFA. Furthermore, iBAT and PVAT, whilst phenotypically 
similar, differ in their response to this brief period of nutrient excess. This is the first study to 
investigate whether these anatomically and developmentally distinct depots [1,2] respond differently 
to a brief caloric surplus, and suggests that not all BAT is similar with regards to its potential to 
regulate nutrient metabolism. 
An important aspect of our study is the finding that adaptations in iBAT and PVAT with rapid 
whole-body weight gain occur prior to increased fat mass and it is likely this weight gain is a 
consequence of lipid accumulation across all fat depots. The changes in iBAT and PVAT could, 
therefore, be early events in the transition from BAT to a whiter phenotype, the development of 
adipose tissue dysfunction and /or adaptations in response to caloric surplus. For instance, PSMA3, 
a component of the core 20S proteasome complex is upregulated in visceral adipose tissue of obese 
rats [31] and is seen here to be upregulated after only 72h of HFD suggesting a potential role in the 
acute and chronic adaptation to HFD in these tissues.  
In BAT however, activation of the proteasome is essential for cold-induced thermogenesis with 
selective induction of proteostasis in BAT improving metabolic activity and body weight 
independent of insulin tolerance in diet-induced obesity [32]. In this study, downregulation of 
Transmembrane Protein 126a (TMEM126a) in iBAT is of particular interest. It is an inner-
mitochondrial, cristae associated transmembrane protein strongly expressed in multiple tissues in 
adult humans and co-localises with ATP synthase F1 subunit alpha (ATP5A) [33,34]. Intriguingly, 
TMEM126 also co-localises with, and binds to, a CD137 ligand (CD137L) in macrophages to regulate 
reverse signaling [35,36]. CD137 is a common marker of beige adipocytes. Whether TMEM126a 
regulates mitochondrial function in iBAT or in the development of beige adipocytes is unknown. 
Another mitochondrial protein, Coiled-Coil Domain Containing 51 (CCDC51), has previously been 
shown to be a target of the transcription factor iroquois homeobox 3 (IRX3). In human obesity, IRX3 
is a target of the FTO risk loci with allele carriers having increased IRX3 expression in early 
adipogenesis where it is proposed to regulate adipocyte function and browning through the 
modulation of mitochondrial genes [37]. 
Our finding that the response to brief nutrient excess differs in PVAT compared to iBAT may be 
explained, in part, by the proximity of PVAT to, and local interaction with, the vascular system. The 
downregulation of Phosphofructokinase, Platelet (PFKP), which catalyses fructose 6-phosphate to 
fructose 1,6-bisphophate, is intriguing given that elevated expression is associated with raised BMI 
and obesity in genome wide association studies [38,39]. In iBAT, however, PFKP expression is 
induced by cold exposure and sympathetic activation with a β3-agonist and reduced at 
thermoneutrality [40]. This is in line with the downregulation of both thermogenic and metabolic 
genes and would suggest perturbed adipocyte function in PVAT. Furthermore, Growth Hormone 
Inducible Transmembrane Protein (GHITM), a mitochondrial protein involved in cristae 
organisation, cytochocrome C release and apoptosis was downregulated [41]. Alongside an 
upregulation of Ubiquitin Conjugating Enzyme E2 N (Ube2n) which regulates the TLR4 signalling 
pathway, and genes governing the inflammasome it points towards a pro-inflammatory, apoptotic 
environment in PVAT following only brief exposure to a HFD. Interestingly, Myotrophin (MTPN) 
and Capping Actin Protein Of Muscle Z-Line Subunit Alpha 1 (CAPZA1), both of which play a role 
in the growth of actin filaments, were upregulated in PVAT. Of these, MTPN drives the growth of 
cardiomyocytes and promotes cardiac hypertrophy, whilst reduced CAPZA1 improves post-
ischemic cardiac function [42,43]. Whether these proteins in PVAT signal to the endothelium to 
regulate vascular remodelling is currently unknown. 
The enrichment of lipid and cholesterol-related GO terms in iBAT are in accordance with a major 
role in lipoprotein metabolism [44,45]. Downregulation of proteins involved in reverse-transport of 
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cholesterol from fat to liver and the formation of high-density lipoproteins and chylomicrons 
(APOA1, 2 and 4) suggests changes in the uptake and processing of triglyceride-rich lipoproteins as 
fuel for iBAT [46]. Alternatively, and in the context of the rapid whole body weight gain, perturbation 
of PPAR signaling including reduced UCP1 and upregulation of white adipose adipokines i.e. 
adiponectin mRNA may indicate early stages of iBAT remodeling towards a white phenotype. In 
contrast, the enrichment of nuclear related GO terms in PVAT are indicative of dynamic changes in 
DNA replication, repair and gene transcription [47–49]. Whether the genes and proteins in these 
nuclear-related pathways act on the vascular wall to regulate vascular function following brief 
exposure to a HFD remains to be determined, as does the extent to which these adaptations can be 
reversed. 
Impact analysis further highlights the divergent response in these two BAT depots with fat 
digestion and absorption glucagon signaling and PPAR signalling among those impacted in iBAT. 
Importantly, downregulation of UCP1 in the PPAR signalling pathway suggests impaired BAT 
function which may contribute to the rapid weight gain seen within 72h. Furthermore, 
downregulation of the long-chain fatty-acid CoA ligase 5 (ACSL5) in the PPAR pathway and the 
Mitochondrial Aspartate Aminotransferase 2 (GOT2), which facilitates cellular long chain fatty acid 
uptake and metabolite exchange between the cytosol and mitochondria, is significant as long-chain 
fatty acids activate UCP1 and are the preferred fuel of BAT for adaptive thermogenesis [5]. Any 
adaptations of this type could modulate NEFA handling and contribute in part to the decline in 
plasma NEFA with the HFD, although TG were unaffected. Conversely in PVAT, impacted pathways 
included retinol metabolism, cell adhesion molecules, ribosome and fluid shear stress and 
atherosclerosis. Retinoic acid regulates adipogenesis and cell migration, differentiation, apoptosis 
and vascular calcification in vascular smooth muscle cells [50]. A downregulation of Retinol Saturase 
(RETSAT) may also be indicative of the early stages of PVAT dysfunction. RETSAT knockout mice 
exhibit increased adiposity due to an upregulation of PPARγ and FABP4 and it is downregulated in 
obese humans where the infiltration of macrophages represses its function [51,52]. Altered cell 
adhesion and shear stress pathways in PVAT are intriguing due to their well-known role in driving 
atherogenesis [53,54]. For instance, the platelet and cell adhesion molecule PECAM1 is essential for 
vascular remodeling in mice with PECAM1 knockout mice, which are partially protected from 
atherosclerosis, exhibiting reduced aortic arch and sinus lesions [55,56]. How these proteins in PVAT 
regulate vascular function is currently unknown but we predict these may be the initial stages of 
PVAT dysfunction in response to a HFD and, as such, could be important in the initial stages of 
vascular dysfunction. 
5. Conclusions 
In conclusion, we show that two anatomically and developmentally distinct BAT depots exhibit 
a divergent response to short-term nutrient excess. We propose these alterations, which occur 
following rapid weight gain but prior to increased fat mass, are of importance in the development of 
subsequent adipocyte dysfunction in obesity.  
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